# OCTREOTIDE ACETATE
> **ANDA210317** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-12-05
## Drug
- **FDA Application Number:** ANDA210317
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OCTREOTIDE ACETATE
- **Generic name:** OCTREOTIDE ACETATE
- **Active ingredients:** OCTREOTIDE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2023-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210317)
---
*AI Analytics · CC0 1.0*